Evidence map›Paper›PMID 32156701›Full record

ArticleThe Journal of biological chemistry2020

Reduction of protein phosphatase 2A (PP2A) complexity reveals cellular functions and dephosphorylation motifs of the PP2A/B'δ holoenzyme.

Chian Ju Jong, Ronald A Merrill, Emily M Wilkerson, Laura E Herring, Lee M Graves, Stefan Strack

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. B56δ long-disordered arms form a dynamic PP2A regulation interface coupled with global allostery and Jordan's syndrome mutations.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Chian Ju JongDepartment of Neuroscience and Pharmacology and Iowa Neuroscience Institute, University of Iowa, Iowa City, Iowa 52242.
Ronald A MerrillDepartment of Neuroscience and Pharmacology and Iowa Neuroscience Institute, University of Iowa, Iowa City, Iowa 52242.
Emily M WilkersonMichael Hooker Proteomics Facility, University of North Carolina, Chapel Hill, North Carolina 27516.
Laura E HerringMichael Hooker Proteomics Facility, University of North Carolina, Chapel Hill, North Carolina 27516.
Lee M GravesMichael Hooker Proteomics Facility, University of North Carolina, Chapel Hill, North Carolina 27516.
Stefan StrackDepartment of Neuroscience and Pharmacology and Iowa Neuroscience Institute, University of Iowa, Iowa City, Iowa 52242. Electronic address: stefan-strack@uiowa.edu.
University of Iowa · USUniversity of North Carolina at Chapel Hill · US

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5M
RESEARCH TRAINING IN HEMATOLOGYT32HL007899 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI Jane Ellen Churpek · 1998 to 2026
$8.2M
Kinase/Phosphatase-mediated Mitochondrial Restructuring in NeuroprotectionR01NS056244 · NINDS · UNIVERSITY OF IOWA · PI STRACK, STEFAN · 2007 to 2016
$2.9M
Outer mitochondrial PKA and PP2A in neurodevelopment and plasticityR21NS087908 · NINDS · UNIVERSITY OF IOWA · PI STRACK, STEFAN · 2014 to 2015
$415k
Kinase/phosphatase-mediated Mitochondrial Restructuring in NeuroprotectionR56NS056244 · NINDS · UNIVERSITY OF IOWA · PI STRACK, STEFAN · 2012 to 2012
$378k
NCI NIH HHS P30 CA016086NHLBI NIH HHS T32 HL007899NINDS NIH HHS R01 NS056244NINDS NIH HHS R21 NS087908NINDS NIH HHS R56 NS056244
6 · The paper itself

Abstract

Protein phosphatase 2A (PP2A) is a large enzyme family responsible for most cellular Ser/Thr dephosphorylation events. PP2A substrate specificity, localization, and regulation by second messengers rely on more than a dozen regulatory subunits (including B/R2, B'/R5, and B″/R3), which form the PP2A heterotrimeric holoenzyme by associating with a dimer comprising scaffolding (A) and catalytic (C) subunits. Because of partial redundancy and high endogenous expression of PP2A holoenzymes, traditional approaches of overexpressing, knocking down, or knocking out PP2A regulatory subunits have yielded only limited insights into their biological roles and substrates. To this end, here we sought to reduce the complexity of cellular PP2A holoenzymes. We used tetracycline-inducible expression of pairs of scaffolding and regulatory subunits with complementary charge-reversal substitutions in their interaction interfaces. For each of the three regulatory subunit families, we engineered A/B charge-swap variants that could bind to one another, but not to endogenous A and B subunits. Because endogenous Aα was targeted by a co-induced shRNA, endogenous B subunits were rapidly degraded, resulting in expression of predominantly a single PP2A heterotrimer composed of the A/B charge-swap pair and the endogenous catalytic subunit. Using B'δ/PPP2R5D, we show that PP2A complexity reduction, but not PP2A overexpression, reveals a role of this holoenzyme in suppression of extracellular signal-regulated kinase signaling and protein kinase A substrate dephosphorylation. When combined with global phosphoproteomics, the PP2A/B'δ reduction approach identified consensus dephosphorylation motifs in its substrates and suggested that residues surrounding the phosphorylation site play roles in PP2A substrate specificity.

Indexed as

AnimalsCatalytic DomainChlorocebus aethiopsCOS CellsHEK293 CellsHumansModels, MolecularPhosphorylationProtein Interaction MapsProtein MultimerizationProtein Phosphatase 2Protein SubunitsPPP2R5D protein, humanProtein Phosphatase 2Protein Subunitsconsensus dephosphorylation motifmass spectrometry (MS)post-translational modificationprotein complexprotein kinase A (PKA)protein phosphataseprotein phosphatase 2 (PP2A)protein phosphorylationprotein serine/threonine phosphatase (PSP)quantitative phosphoproteomicsRNA interferencesalt bridgesignal transductionsubstrate specificity

Identifiers

PMID32156701
PMCPMC7186168
OpenAlexW3011515036

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.